J.S. de Jong

1.0k total citations
12 papers, 854 citations indexed

About

J.S. de Jong is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, J.S. de Jong has authored 12 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in J.S. de Jong's work include Cancer-related Molecular Pathways (4 papers), Angiogenesis and VEGF in Cancer (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). J.S. de Jong is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Angiogenesis and VEGF in Cancer (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). J.S. de Jong collaborates with scholars based in Netherlands and United States. J.S. de Jong's co-authors include P. J. van Diest, Jan P. A. Baak, Paul van der Valk, J. P. A. Baak, Rob Michalides, P J van Diest, Petra van der Groep, Elsken van der Wall, Reinhard Bos and Paul van der Valk and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Journal of Clinical Pathology.

In The Last Decade

J.S. de Jong

12 papers receiving 829 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.S. de Jong Netherlands 11 443 390 297 185 88 12 854
Joachim Bellach Germany 8 315 0.7× 519 1.3× 177 0.6× 119 0.6× 49 0.6× 13 844
Jan Dominik Kuhlmann Germany 18 510 1.2× 446 1.1× 486 1.6× 131 0.7× 46 0.5× 62 1.1k
Yoshiyuki Kobayashi Japan 21 268 0.6× 266 0.7× 227 0.8× 222 1.2× 80 0.9× 54 1.3k
E Horak United Kingdom 8 667 1.5× 438 1.1× 411 1.4× 119 0.6× 112 1.3× 11 1.0k
Harriette Kahn Canada 15 375 0.8× 365 0.9× 222 0.7× 95 0.5× 136 1.5× 23 864
Sajida Piperdi United States 17 410 0.9× 521 1.3× 222 0.7× 464 2.5× 59 0.7× 25 1.1k
Bernhard Polzer Germany 16 405 0.9× 791 2.0× 620 2.1× 237 1.3× 46 0.5× 34 1.2k
Klaus J. Weber Germany 13 411 0.9× 247 0.6× 227 0.8× 208 1.1× 152 1.7× 28 781
Letizia Perracchio Italy 16 382 0.9× 315 0.8× 168 0.6× 110 0.6× 80 0.9× 33 801
Lorenza Pistola Italy 17 472 1.1× 502 1.3× 281 0.9× 414 2.2× 118 1.3× 38 982

Countries citing papers authored by J.S. de Jong

Since Specialization
Citations

This map shows the geographic impact of J.S. de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.S. de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.S. de Jong more than expected).

Fields of papers citing papers by J.S. de Jong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.S. de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.S. de Jong. The network helps show where J.S. de Jong may publish in the future.

Co-authorship network of co-authors of J.S. de Jong

This figure shows the co-authorship network connecting the top 25 collaborators of J.S. de Jong. A scholar is included among the top collaborators of J.S. de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.S. de Jong. J.S. de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Harlaar, Niels J., Jan Willem Hesselink, J.S. de Jong, & Gooitzen M. van Dam. (2010). Bioluminescence as Gold Standard for Validation of Optical Imaging Modalities in Peritoneal Carcinomatosis Animal Models. European Surgical Research. 45(3-4). 308–313. 5 indexed citations
2.
Pleijhuis, Rick G., Wijnand Helfrich, George Themelis, et al.. (2010). Near-infrared fluorescence (NIRF) imaging in breast-conserving surgery: Assessing intraoperative techniques in tissue-simulating breast phantoms. European Journal of Surgical Oncology. 37(1). 32–39. 73 indexed citations
3.
Jong, J.S. de, et al.. (2010). FDG-PET probe-guided surgery for recurrent retroperitoneal testicular tumor recurrences. European Journal of Surgical Oncology. 36(11). 1092–1095. 10 indexed citations
4.
Bos, Reinhard, P. J. van Diest, J.S. de Jong, et al.. (2005). Hypoxia‐inducible factor‐1α is associated with angiogenesis, and expression of bFGF, PDGF‐BB, and EGFR in invasive breast cancer. Histopathology. 46(1). 31–36. 153 indexed citations
5.
Jong, J.S. de, P. J. van Diest, & J. P. A. Baak. (2000). Number of apoptotic cells as a prognostic marker in invasive breast cancer. British Journal of Cancer. 82(2). 368–373. 71 indexed citations
6.
Jong, J.S. de, P J van Diest, Rob Michalides, & Jan P. A. Baak. (1999). Concerted overexpression of the genes encoding p21 and cyclin D1 is associated with growth inhibition and differentiation in various carcinomas.. Molecular Pathology. 52(2). 78–83. 33 indexed citations
7.
Beliën, Jeroen A.M., et al.. (1999). Fully automated microvessel counting and hot spot selection by image processing of whole tumour sections in invasive breast cancer.. Journal of Clinical Pathology. 52(3). 184–192. 66 indexed citations
8.
Jong, J.S. de, P J van Diest, Rob Michalides, et al.. (1998). Correlation of cyclin D1 and Rb gene expression with apoptosis in invasive breast cancer. Molecular Pathology. 51(1). 30–34. 14 indexed citations
9.
Valk, Paul van der, J.S. de Jong, W. Devillé, et al.. (1997). Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.. Journal of Clinical Oncology. 15(6). 2456–2466. 137 indexed citations
10.
Diest, P J van, Rob Michalides, Paul van der Valk, et al.. (1997). Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value.. PubMed. 150(2). 705–11. 174 indexed citations
11.
Jong, J.S. de, et al.. (1996). Counting of apoptotic cells: a methodological study in invasive breast cancer. Molecular Pathology. 49(4). M214–M217. 37 indexed citations
12.
Jong, J.S. de, P. J. van Diest, & Jan P. A. Baak. (1995). Heterogeneity and reproducibility of microvessel counts in breast cancer.. PubMed. 73(6). 922–6. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026